FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
As we reported on CDN blog FDA approval for Janssen vaccine containing HPBCD was expected in late February. The Janssen
Tag: Vaccine
HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
Amongst Janssen’s novel single-dose Covid-19 vaccine candidate of adenovirus platform excipients one might notice a peculiar compound: Hydroxypropyl Betadex (HPBCD).
Pfizer and BioNTech announced vaccine candidate against covid-19 achieved success in first interim analysis from Phase 3 study
Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective Pfizer and BioNTech announced on 09 October their mRNA-based vaccine
Nasal administration of COVID-19 vaccine
Researchers lead by Professor Michael S. Diamond at Washington University School of Medicine in St. Louis, have developed a COVID-19
Dental Tribune on Cyclodextrins in Covid-19
With the title “How cyclodextrins work: Five things we learned from Roquette“, Dental Tribune gives a summary on the roles
Two coronavirus vaccines show immune response in human trials
Advanced Science News published on the results of clinical trials of two vaccines against SARS-CoV-2. Three months ago, the University of
15 PhD positions in vaccine research
Applications are invited for 15 three-year PhD studentships to be funded by the Marie- Skłodowska-Curie Innovative Training Network “BactiVax” within
Cyclodextrins in veterinary medicine (Part 2)
In our previous post we talked about the “classical” usage of cyclodextrins in veterinary medicine. Now let’s see some non-usual
DIMEB in biotechnology
Heptakis(2,6-di-O-methyl) beta-cyclodextrin is a single isomer with high solubility in cold water, but it crystallizes from water at increased temperatures.
A clinical phase1 study of Hydroxypropyl-beta-cyclodextrin (HPBCD)-adjuvanted influenza split vaccine
Osaka University Hospital with the support of Daichii Sankyo is sponsoring a clinical trial on a vaccine against influenza virus.